<?xml version="1.0"?>
<feed xmlns="http://www.w3.org/2005/Atom" xml:lang="de">
	<id>https://ddn.pluspedia.org/w/index.php?action=history&amp;feed=atom&amp;title=SARS-CoV-2-Variante_Delta</id>
	<title>SARS-CoV-2-Variante Delta - Versionsgeschichte</title>
	<link rel="self" type="application/atom+xml" href="https://ddn.pluspedia.org/w/index.php?action=history&amp;feed=atom&amp;title=SARS-CoV-2-Variante_Delta"/>
	<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=SARS-CoV-2-Variante_Delta&amp;action=history"/>
	<updated>2026-08-12T18:11:18Z</updated>
	<subtitle>Versionsgeschichte dieser Seite in PlusPedia</subtitle>
	<generator>MediaWiki 1.43.3</generator>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=SARS-CoV-2-Variante_Delta&amp;diff=798765&amp;oldid=prev</id>
		<title>Fmrauch am 10. Januar 2022 um 22:41 Uhr</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=SARS-CoV-2-Variante_Delta&amp;diff=798765&amp;oldid=prev"/>
		<updated>2022-01-10T22:41:18Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;de&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Nächstältere Version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Version vom 10. Januar 2022, 22:41 Uhr&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Zeile 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Zeile 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Die &#039;&#039;&#039;SARS-CoV-2-Variante Delta&#039;&#039;&#039; ist eine Variante des Coronavirus [[SARS-CoV-2]]. Das erste Auftreten wurde für den Oktober 2020 in [[Indien]],&amp;lt;ref name=&quot;whoEpi20210601&quot;&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210601_weekly_epi_update_42.pdf |titel=COVID-19 Weekly Epidemiological Update Edition 42&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;, published 1 June 2021 &lt;/del&gt;|hrsg=who.int |datum=2021&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-06-01 &lt;/del&gt;|seiten=5 |zugriff=2021-09-05 |format=PDF |sprache=en |zitat=WHO label […] Delta B.1.617.2 […] Earliest documented samples […] India, Oct-2020 […] VOI: 4-Apr-2021, VOC: 11-May-2021}}&amp;lt;/ref&amp;gt; und zwar im Bundesstaat [[Maharashtra]] nachgewiesen.&amp;lt;ref name=&quot;nature20210906&quot;&amp;gt;{{Internetquelle |autor=Mlcochova, P. et al. in [[Nature]] |url=https://www.nature.com/articles/s41586-021-03944-y_reference.pdf |titel=SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion |hrsg=nature.com |datum=2021-09-06 |zugriff=2021-09-07 |format=PDF; 19,5 MB |sprache=en |kommentar=has been accepted for publication |zitat=B.1.617.2 (Delta) variant was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages including B.1.617.1 (Kappa) and B.1.1.7 (Alpha). In vitro, B.1.617.2 is 6-fold less sensitive to serum neutralising antibodies from recovered individuals, and 8-fold less sensitive to vaccine-elicited antibodies as compared to wild type (WT) Wuhan-1 bearing D614G. […] Additionally we observed that B.1.617.2 had higher replication and spike mediated entry as compared to B.1.617.1, potentially explaining B.1.617.2 dominance.}} [[doi:10.1038/s41586-021-03944-y]], PMID 34488225&amp;lt;/ref&amp;gt; Ab Juli 2021 war Delta die bestimmende Variante weltweit,&amp;lt;ref&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-8th-meeting-of-the-ihr-emergency-committee-on-covid-19-14-july-2021 |titel=WHO Director-General&#039;s opening remarks at the 8th meeting of the IHR Emergency Committee on COVID-19 &lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;– 14 July 2021 &lt;/del&gt;|hrsg=who.int |datum=2021&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;-07-14 &lt;/del&gt;|zugriff=2021-09-06 |sprache=en |zitat=The Delta variant is now in more than 111 countries and we expect it to soon be the dominant COVID-19 strain circulating worldwide, if it isn’t already. The Delta variant is one of the main drivers of the current increase in transmission, fuelled by increased social mixing and mobility, and inconsistent use of proven public health and social measures. At the same time, we continue to see a shocking disparity in the global distribution of vaccines, and unequal access to life-saving tools.}}&amp;lt;/ref&amp;gt; in Deutschland hatte sie Ende August 2021 einen Anteil von 99,3 %.&amp;lt;ref name=&quot;RKI20210826&quot; /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Die &#039;&#039;&#039;SARS-CoV-2-Variante Delta&#039;&#039;&#039; ist eine Variante des Coronavirus [[SARS-CoV-2]]. Das erste Auftreten wurde für den Oktober 2020 in [[Indien]],&amp;lt;ref name=&quot;whoEpi20210601&quot;&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210601_weekly_epi_update_42.pdf |titel=COVID-19 Weekly Epidemiological Update Edition 42|hrsg=who.int |datum=&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;1. Juni &lt;/ins&gt;2021 |seiten=5 |zugriff=2021-09-05 |format=PDF |sprache=en |zitat=WHO label […] Delta B.1.617.2 […] Earliest documented samples […] India, Oct-2020 […] VOI: 4-Apr-2021, VOC: 11-May-2021}}&amp;lt;/ref&amp;gt; und zwar im Bundesstaat [[Maharashtra]] nachgewiesen.&amp;lt;ref name=&quot;nature20210906&quot;&amp;gt;{{Internetquelle |autor=Mlcochova, P. et al. in [[Nature]] |url=https://www.nature.com/articles/s41586-021-03944-y_reference.pdf |titel=SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion |hrsg=nature.com |datum=2021-09-06 |zugriff=2021-09-07 |format=PDF; 19,5 MB |sprache=en |kommentar=has been accepted for publication |zitat=B.1.617.2 (Delta) variant was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages including B.1.617.1 (Kappa) and B.1.1.7 (Alpha). In vitro, B.1.617.2 is 6-fold less sensitive to serum neutralising antibodies from recovered individuals, and 8-fold less sensitive to vaccine-elicited antibodies as compared to wild type (WT) Wuhan-1 bearing D614G. […] Additionally we observed that B.1.617.2 had higher replication and spike mediated entry as compared to B.1.617.1, potentially explaining B.1.617.2 dominance.}} [[doi:10.1038/s41586-021-03944-y]], PMID 34488225&amp;lt;/ref&amp;gt; Ab Juli 2021 war Delta die bestimmende Variante weltweit,&amp;lt;ref&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-8th-meeting-of-the-ihr-emergency-committee-on-covid-19-14-july-2021 |titel=WHO Director-General&#039;s opening remarks at the 8th meeting of the IHR Emergency Committee on COVID-19|hrsg=who.int |datum=&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;14. Juli &lt;/ins&gt;2021|zugriff=2021-09-06 |sprache=en |zitat=The Delta variant is now in more than 111 countries and we expect it to soon be the dominant COVID-19 strain circulating worldwide, if it isn’t already. The Delta variant is one of the main drivers of the current increase in transmission, fuelled by increased social mixing and mobility, and inconsistent use of proven public health and social measures. At the same time, we continue to see a shocking disparity in the global distribution of vaccines, and unequal access to life-saving tools.}}&amp;lt;/ref&amp;gt; in Deutschland hatte sie Ende August 2021 einen Anteil von 99,3 %.&amp;lt;ref name=&quot;RKI20210826&quot;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;gt;{{Internetquelle |url=https://www.rki.de/DE/Content/InfAZ/N/Neuartiges_Coronavirus/Situationsberichte/Wochenbericht/Wochenberichte_Tab.html |titel=Wöchentlicher Lagebericht des RKI zur Coronavirus-Krankheit-2019 (COVID-19)  |werk=Wochenberichte zu COVID-19 |hrsg=rki.de |datum=26.08.2021 |seiten=25 |zugriff=2021-08-27}}&amp;lt;&lt;/ins&gt;/&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;ref&lt;/ins&gt;&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;br&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Einzelnachweise ==&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot;&gt;&lt;/td&gt;&lt;td style=&quot;background-color: #f8f9fa; color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #eaecf0; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;== Einzelnachweise ==&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Fmrauch</name></author>
	</entry>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=SARS-CoV-2-Variante_Delta&amp;diff=798764&amp;oldid=prev</id>
		<title>Fmrauch am 10. Januar 2022 um 22:36 Uhr</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=SARS-CoV-2-Variante_Delta&amp;diff=798764&amp;oldid=prev"/>
		<updated>2022-01-10T22:36:54Z</updated>

		<summary type="html">&lt;p&gt;&lt;/p&gt;
&lt;table style=&quot;background-color: #fff; color: #202122;&quot; data-mw=&quot;interface&quot;&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;col class=&quot;diff-marker&quot; /&gt;
				&lt;col class=&quot;diff-content&quot; /&gt;
				&lt;tr class=&quot;diff-title&quot; lang=&quot;de&quot;&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;← Nächstältere Version&lt;/td&gt;
				&lt;td colspan=&quot;2&quot; style=&quot;background-color: #fff; color: #202122; text-align: center;&quot;&gt;Version vom 10. Januar 2022, 22:36 Uhr&lt;/td&gt;
				&lt;/tr&gt;&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot; id=&quot;mw-diff-left-l1&quot;&gt;Zeile 1:&lt;/td&gt;
&lt;td colspan=&quot;2&quot; class=&quot;diff-lineno&quot;&gt;Zeile 1:&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;−&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #ffe49c; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Die &#039;&#039;&#039;SARS-CoV-2-Variante Delta&#039;&#039;&#039; ist eine Variante des Coronavirus [[SARS-CoV-2]]. Das erste Auftreten wurde für den Oktober 2020 in [[Indien]],&amp;lt;ref name=&quot;whoEpi20210601&quot;&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210601_weekly_epi_update_42.pdf |titel=COVID-19 Weekly Epidemiological Update Edition 42, published 1 June 2021 |hrsg=who.int |datum=2021-06-01 |seiten=5 |zugriff=2021-09-05 |format=PDF |sprache=en |zitat=WHO label […] Delta B.1.617.2 […] Earliest documented samples […] India, Oct-2020 […] VOI: 4-Apr-2021, VOC: 11-May-2021}}&amp;lt;/ref&amp;gt; und zwar im Bundesstaat [[Maharashtra]] nachgewiesen.&amp;lt;ref name=&quot;nature20210906&quot;&amp;gt;{{Internetquelle |autor=Mlcochova, P. et al. in [[Nature]] |url=https://www.nature.com/articles/s41586-021-03944-y_reference.pdf |titel=SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion |hrsg=nature.com |datum=2021-09-06 |zugriff=2021-09-07 |format=PDF; 19,5 MB |sprache=en |kommentar=has been accepted for publication |zitat=B.1.617.2 (Delta) variant was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages including B.1.617.1 (Kappa) and B.1.1.7 (Alpha). In vitro, B.1.617.2 is 6-fold less sensitive to serum neutralising antibodies from recovered individuals, and 8-fold less sensitive to vaccine-elicited antibodies as compared to wild type (WT) Wuhan-1 bearing D614G. […] Additionally we observed that B.1.617.2 had higher replication and spike mediated entry as compared to B.1.617.1, potentially explaining B.1.617.2 dominance.}} [[doi:10.1038/s41586-021-03944-y]], PMID 34488225&amp;lt;/ref&amp;gt; Ab Juli 2021 war Delta die bestimmende Variante weltweit,&amp;lt;ref&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-8th-meeting-of-the-ihr-emergency-committee-on-covid-19-14-july-2021 |titel=WHO Director-General&#039;s opening remarks at the 8th meeting of the IHR Emergency Committee on COVID-19 – 14 July 2021 |hrsg=who.int |datum=2021-07-14 |&lt;del style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;abruf&lt;/del&gt;=2021-09-06 |sprache=en |zitat=The Delta variant is now in more than 111 countries and we expect it to soon be the dominant COVID-19 strain circulating worldwide, if it isn’t already. The Delta variant is one of the main drivers of the current increase in transmission, fuelled by increased social mixing and mobility, and inconsistent use of proven public health and social measures. At the same time, we continue to see a shocking disparity in the global distribution of vaccines, and unequal access to life-saving tools.}}&amp;lt;/ref&amp;gt; in Deutschland hatte sie Ende August 2021 einen Anteil von 99,3 %.&amp;lt;ref name=&quot;RKI20210826&quot; /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;Die &#039;&#039;&#039;SARS-CoV-2-Variante Delta&#039;&#039;&#039; ist eine Variante des Coronavirus [[SARS-CoV-2]]. Das erste Auftreten wurde für den Oktober 2020 in [[Indien]],&amp;lt;ref name=&quot;whoEpi20210601&quot;&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210601_weekly_epi_update_42.pdf |titel=COVID-19 Weekly Epidemiological Update Edition 42, published 1 June 2021 |hrsg=who.int |datum=2021-06-01 |seiten=5 |zugriff=2021-09-05 |format=PDF |sprache=en |zitat=WHO label […] Delta B.1.617.2 […] Earliest documented samples […] India, Oct-2020 […] VOI: 4-Apr-2021, VOC: 11-May-2021}}&amp;lt;/ref&amp;gt; und zwar im Bundesstaat [[Maharashtra]] nachgewiesen.&amp;lt;ref name=&quot;nature20210906&quot;&amp;gt;{{Internetquelle |autor=Mlcochova, P. et al. in [[Nature]] |url=https://www.nature.com/articles/s41586-021-03944-y_reference.pdf |titel=SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion |hrsg=nature.com |datum=2021-09-06 |zugriff=2021-09-07 |format=PDF; 19,5 MB |sprache=en |kommentar=has been accepted for publication |zitat=B.1.617.2 (Delta) variant was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages including B.1.617.1 (Kappa) and B.1.1.7 (Alpha). In vitro, B.1.617.2 is 6-fold less sensitive to serum neutralising antibodies from recovered individuals, and 8-fold less sensitive to vaccine-elicited antibodies as compared to wild type (WT) Wuhan-1 bearing D614G. […] Additionally we observed that B.1.617.2 had higher replication and spike mediated entry as compared to B.1.617.1, potentially explaining B.1.617.2 dominance.}} [[doi:10.1038/s41586-021-03944-y]], PMID 34488225&amp;lt;/ref&amp;gt; Ab Juli 2021 war Delta die bestimmende Variante weltweit,&amp;lt;ref&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-8th-meeting-of-the-ihr-emergency-committee-on-covid-19-14-july-2021 |titel=WHO Director-General&#039;s opening remarks at the 8th meeting of the IHR Emergency Committee on COVID-19 – 14 July 2021 |hrsg=who.int |datum=2021-07-14 |&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;zugriff&lt;/ins&gt;=2021-09-06 |sprache=en |zitat=The Delta variant is now in more than 111 countries and we expect it to soon be the dominant COVID-19 strain circulating worldwide, if it isn’t already. The Delta variant is one of the main drivers of the current increase in transmission, fuelled by increased social mixing and mobility, and inconsistent use of proven public health and social measures. At the same time, we continue to see a shocking disparity in the global distribution of vaccines, and unequal access to life-saving tools.}}&amp;lt;/ref&amp;gt; in Deutschland hatte sie Ende August 2021 einen Anteil von 99,3 %.&amp;lt;ref name=&quot;RKI20210826&quot; /&amp;gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;== Einzelnachweise ==&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;&amp;lt;references /&amp;gt;&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;{{PPA-Kupfer}}&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt; &lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;tr&gt;&lt;td colspan=&quot;2&quot; class=&quot;diff-side-deleted&quot;&gt;&lt;/td&gt;&lt;td class=&quot;diff-marker&quot; data-marker=&quot;+&quot;&gt;&lt;/td&gt;&lt;td style=&quot;color: #202122; font-size: 88%; border-style: solid; border-width: 1px 1px 1px 4px; border-radius: 0.33em; border-color: #a3d3ff; vertical-align: top; white-space: pre-wrap;&quot;&gt;&lt;div&gt;&lt;ins style=&quot;font-weight: bold; text-decoration: none;&quot;&gt;[[Kategorie:COVID-19-Pandemie]]&lt;/ins&gt;&lt;/div&gt;&lt;/td&gt;&lt;/tr&gt;
&lt;/table&gt;</summary>
		<author><name>Fmrauch</name></author>
	</entry>
	<entry>
		<id>https://ddn.pluspedia.org/w/index.php?title=SARS-CoV-2-Variante_Delta&amp;diff=798763&amp;oldid=prev</id>
		<title>Fmrauch: Die Seite wurde neu angelegt: „Die &#039;&#039;&#039;SARS-CoV-2-Variante Delta&#039;&#039;&#039; ist eine Variante des Coronavirus SARS-CoV-2. Das erste Auftreten wurde für den Oktober 2020 in Indien,&lt;ref name=&quot;…“</title>
		<link rel="alternate" type="text/html" href="https://ddn.pluspedia.org/w/index.php?title=SARS-CoV-2-Variante_Delta&amp;diff=798763&amp;oldid=prev"/>
		<updated>2022-01-10T22:35:52Z</updated>

		<summary type="html">&lt;p&gt;Die Seite wurde neu angelegt: „Die &amp;#039;&amp;#039;&amp;#039;SARS-CoV-2-Variante Delta&amp;#039;&amp;#039;&amp;#039; ist eine Variante des Coronavirus &lt;a href=&quot;/wiki/SARS-CoV-2&quot; title=&quot;SARS-CoV-2&quot;&gt;SARS-CoV-2&lt;/a&gt;. Das erste Auftreten wurde für den Oktober 2020 in &lt;a href=&quot;/wiki/Indien&quot; title=&quot;Indien&quot;&gt;Indien&lt;/a&gt;,&amp;lt;ref name=&amp;quot;…“&lt;/p&gt;
&lt;p&gt;&lt;b&gt;Neue Seite&lt;/b&gt;&lt;/p&gt;&lt;div&gt;Die &amp;#039;&amp;#039;&amp;#039;SARS-CoV-2-Variante Delta&amp;#039;&amp;#039;&amp;#039; ist eine Variante des Coronavirus [[SARS-CoV-2]]. Das erste Auftreten wurde für den Oktober 2020 in [[Indien]],&amp;lt;ref name=&amp;quot;whoEpi20210601&amp;quot;&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/docs/default-source/coronaviruse/situation-reports/20210601_weekly_epi_update_42.pdf |titel=COVID-19 Weekly Epidemiological Update Edition 42, published 1 June 2021 |hrsg=who.int |datum=2021-06-01 |seiten=5 |zugriff=2021-09-05 |format=PDF |sprache=en |zitat=WHO label […] Delta B.1.617.2 […] Earliest documented samples […] India, Oct-2020 […] VOI: 4-Apr-2021, VOC: 11-May-2021}}&amp;lt;/ref&amp;gt; und zwar im Bundesstaat [[Maharashtra]] nachgewiesen.&amp;lt;ref name=&amp;quot;nature20210906&amp;quot;&amp;gt;{{Internetquelle |autor=Mlcochova, P. et al. in [[Nature]] |url=https://www.nature.com/articles/s41586-021-03944-y_reference.pdf |titel=SARS-CoV-2 B.1.617.2 Delta variant replication and immune evasion |hrsg=nature.com |datum=2021-09-06 |zugriff=2021-09-07 |format=PDF; 19,5 MB |sprache=en |kommentar=has been accepted for publication |zitat=B.1.617.2 (Delta) variant was first identified in the state of Maharashtra in late 2020 and spread throughout India, outcompeting pre-existing lineages including B.1.617.1 (Kappa) and B.1.1.7 (Alpha). In vitro, B.1.617.2 is 6-fold less sensitive to serum neutralising antibodies from recovered individuals, and 8-fold less sensitive to vaccine-elicited antibodies as compared to wild type (WT) Wuhan-1 bearing D614G. […] Additionally we observed that B.1.617.2 had higher replication and spike mediated entry as compared to B.1.617.1, potentially explaining B.1.617.2 dominance.}} [[doi:10.1038/s41586-021-03944-y]], PMID 34488225&amp;lt;/ref&amp;gt; Ab Juli 2021 war Delta die bestimmende Variante weltweit,&amp;lt;ref&amp;gt;{{Internetquelle |autor=[[WHO]] |url=https://www.who.int/director-general/speeches/detail/who-director-general-s-opening-remarks-at-the-8th-meeting-of-the-ihr-emergency-committee-on-covid-19-14-july-2021 |titel=WHO Director-General&amp;#039;s opening remarks at the 8th meeting of the IHR Emergency Committee on COVID-19 – 14 July 2021 |hrsg=who.int |datum=2021-07-14 |abruf=2021-09-06 |sprache=en |zitat=The Delta variant is now in more than 111 countries and we expect it to soon be the dominant COVID-19 strain circulating worldwide, if it isn’t already. The Delta variant is one of the main drivers of the current increase in transmission, fuelled by increased social mixing and mobility, and inconsistent use of proven public health and social measures. At the same time, we continue to see a shocking disparity in the global distribution of vaccines, and unequal access to life-saving tools.}}&amp;lt;/ref&amp;gt; in Deutschland hatte sie Ende August 2021 einen Anteil von 99,3 %.&amp;lt;ref name=&amp;quot;RKI20210826&amp;quot; /&amp;gt;&lt;/div&gt;</summary>
		<author><name>Fmrauch</name></author>
	</entry>
</feed>